The Expression of Interest is now closed. We sincerely appreciate the EOI's received up to date. The Review Board is now undergoing the review process and will send out the invitation for full proposals to the candidates selected in due course. In the meantime if you have any questions or comments regarding this request for proposals please feel free to contact us at email@example.com.
BGI Australia issues a Request for Proposals (RFP) for single or multi-year collaboration projects with BGI researchers, focusing on applying next-generation sequencing to study the genomic basis of evolution and biodiversity and to understand the impacts of environmental, climate and ecological factors to the biodiversity with an emphasis on the Queensland Government research priority area. For each qualifying proposal BGI Australia will award up to $200,000 of sequencing costs to be performed on the BGI sequencing platform (www.seq500.com) at BGI Australia laboratory in Brisbane.
Timetable for Proposals
• Aug 14, 2017: Announcement of call for proposals
• Sep 15, 2017: Deadline for expressions of interest
• Sep 29, 2017: Invitation for full proposals
• Oct 27, 2017: Deadline for submission of invited proposals
• Nov 10, 2017: Final funding decision communicated by BGI Australia
You may download the full RFP file here below.
You may download the full RFP PDF file here
Due to BGI's growing presence and influence in the world, BGI Australia was established in August 2016 to support its growth in the Asia-Pacific region. Its office is located at the prestigious QIMR Berghofer Medical Research Institute in Herston, Brisbane, Queensland. BGI Australia will continuously pursue collaborative opportunities throughout Queensland and Australia to pursue scientific excellence.
BGI Australia Laboratory, which is BGI’s first southern hemisphere genomics laboratory, is launched in May 2017, unveiling of its cutting-edge sequencer's debut in this part of the world. Being the world's largest genomic organisation with leading gene sequencing platform and superb genome sequencing and bioinformatics analysis capability, BGI Australia is devoted to facilitating cutting-edge research in the areas of healthcare, agriculture and environment.
BGI Australia has established collaborations with leading research institutions such as QIMR Berghofer Medical Research Institute, CSIRO, the University of Queensland, Griffith University and James Cook University to carry out scientific research and innovative projects in relation to human medicine, health science, sports science, marine science, biodiversity, agriculture and aquaculture. BGI Australia has been undergoing strategic discussions with universities and various organisations regarding future opportunities and partnerships.
Since the inception in August 2016, BGI Australia have established extensive collaborations with universities and research institutes all over Australia.
In Aug. 2016 BGI Agriculture Group signed a memorandum with Commonwealth Scientific and Industrial Research Organisation through its Agriculture and Food Business Unit in respect of millet breeding, production and genetic improvement.
In Aug. 2016 BGI Australia signed a memorandum with Griffith University with regards to a number of projects involving genomics, gene sequencing, genetic diagnostic and screening, phonemics and other -omics studies.
BGI and QIMR Berghofer Medical Research Institute signed a memorandum regarding collaborations on a genomics-based research and education programme focused on precision medicine.
BGI Australia and the University of Melbourne signed a Memorandum of Understanding to engage in scientific collaborations in the area of One Health using ‘omic and informatic technologies, with the aim to build a comprehensive, world-class program and joint-centre in infectious diseases.
BGI and Centre for Advanced Imaging University of Queensland formed a partnership to investigate the feasibility of integrating anatomical ultra-high field MRI and genomics sequencing data, with the aim of developing early diagnostic tools across a broad range of clinically significant disorders.
BGI Research is dedicated to using the world class genomics platform to contribute to the public health. Relying on innovative integration of platforms to achieve major scientific breakthroughs in the basic research area and lead technology development, BGI Research has four major areas of focus: Personal genomics, Cancer, Reproductive health, and Molecular breeding.
BGI College focus on innovative education and training for multidisciplinary talents in bioscience and bioindustry. Programs include joint education, external training (bioinformatics training, medical related training & genetic counselor training) and public education (popular science education & summer internship). More than 100 PhD students and 300 MSc students have been trained.
BGI is responsible for the development of the China National Genebank, which is a platform integrating a large-scale bio-repository and an omics database. The mission is to collect, preserve and utilize genomics resources, and to build a network fostering global communication and collaboration on biodiversity conservation and genetic resources utilization. We have collected over 11.3 million samples (including human, animal, plant and microbe).
GigaScience is a new open-access open-data journal for the publication of all types of biological studies that use or create large-scale data sets. With the goal of revolutionizing data accessibility, dissemination, organization, and use, GigaScience has a unique format that integrates article publication with the data-hosting and cloud-computing resources. In three years, GigaDB has stored over 194 datasets and 36TB data.
BGI Agriculture Group, has an extensive scope including animal & plant new variety development, plantation, livestock breeding, agricultural product processing as well as circular ecological research and application with the aim to establish sustainable agricultural industry and guard national food security. It has a major focus on millet breeding, improvement and industry.
BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. BGI Genomics’ mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions for everybody.
BGI Forensics supplies the scientific, accurate and affordable DNA genotyping services, and standardizes the procedures for applying relevant technologies in the fields of human DNA identification, plant and animal identification and forensics science.
MGI is focused on the development, production and distribution of in vitro diagnostic reagents, medical devices, research reagents and equipments. BGI became the first organization with the CFDA registration of next generation sequencing diagnostic products and medical devices. BGI acquired Complete Genomics, a Mountain View based sequencing technology company in 2013. In 2015, based on CG’s technology, MGI launched a new desktop high-throughput next-gen sequencer BGISEQ-500 and in 2016, BGISEQ-50.
BGI was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has a proven track record of innovative, high profile research, which has generated over 2,000 publications, many in top tier journals such as Nature and Science. The organization also contributes to scientific communication by publishing the international research journal GigaScience. BGI’s distinguished achievements have made a significant contribution to the development of genomics throughout the world. BGI’s goal is to make state of-the-art genomics highly accessible to the global research community and clinical markets by integrating the industry’s broadest array of leading technologies, including BGI's own BGISEQ sequencing platform, economies of scale, and expert bioinformatics resources. BGI also offers a wide portfolio of transformative genetic testing products across major diseases, enabling medical providers and patients worldwide to realize the promise of genomics-based diagnostics and personalized healthcare. BGI’s services and solutions are available in more than 60 countries around the world. Please visit the BGI Group website www.genomics.cn for more information.
Chinese sequencing giant BGI and the China National GeneBank (CNGB) held a workshop in July on the sidelines of the International Botanical Congress, being held this week in BGI's hometown of Shenzhen, to discuss what they are calling the 10KP plan. The 10KP plan will be a key part of the Earth BioGenome Project (EBP), an ambitious and still evolving scheme to get at least rough sequence data on the 1.5 million eukaryotic species, starting with detailed sequences of one member of each of the 9000 eukaryotic families. Keep reading
Scientists have put together a Danish reference genome, based on the de novo assembly of 150 genomes from 50 family trios, highlighting the use of deep sequencing to discover a "rich set" of population-specific structural variation. While the genome, published in Nature today, caps years of work for the investigators behind the study, they also believe it has set a precedent for cross-institution collaboration that should encourage scientists in the Scandinavian country as they embark on a new, national personalized medicine program. Keep reading
BGI Genomics Announces Pricing of Initial Public Offering BGI Genomics, an independent division of BGI Group, recently announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. Keep reading
Life Science research to benefit as global genomics specialist formalises ties with the University of Queensland Cancer Advanced Imaging to develop early diagnostic tools for epilepsy. Keep reading
BGI Australia and the University of Melbourne have signed a MOU to engage in scientific collaborations in the area of One Health using -omic and informatic technologies with the aim to build a comprehensive, world-class program and joint-centre in infectious diseases. Keep readingeveloped by global genomics company BGI, the BGISEQ-500 genomics sequencer will operate from the company’s new Australian headquarters at the QIMR Berghofer Medical Research Institute. It is the only genomics sequencer of its kind in the Southern Hemisphere. Keep reading
Developed by global genomics company BGI, the BGISEQ-500 genomics sequencer will operate from the company’s new Australian headquarters at the QIMR Berghofer Medical Research Institute. It is the only genomics sequencer of its kind in the Southern Hemisphere. Keep reading
BGI in Australia Tour Sydney Stop
BGI Australia continuously seek collaborative opportunities throughout Australia to maintain scientific excellence.
R913, L9, 300 Herston Road, Herston, Brisbane, QLD 4006, AU
Monday - Friday: 9am - 5pm
Saturday & Sunday: Closed